Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature
暂无分享,去创建一个
Grietje Molema | Philip E. Thorpe | Xianming Huang | G. Molema | T. Edgington | P. Thorpe | Linda Watkins | Steven King | Thomas S. Edgington | Xianming Huang | S. King | L. Watkins
[1] K. Mann,et al. Role of the membrane surface in the activation of human coagulation factor X. , 1992, The Journal of biological chemistry.
[2] G. Thurston,et al. Tumour-derived factors which induce endothelial tissue factor and enhance the procoagulant response to TNF. , 1991, International journal of radiation biology.
[3] M. Greaves,et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[4] A. Gazdar,et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] Y. Nemerson,et al. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. , 1986, Biochemistry.
[6] J. Folkman,et al. The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.
[7] Harold E. Dvorak,et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels , 1991, The Journal of experimental medicine.
[8] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[9] F. Burrows,et al. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] R K Jain,et al. Barriers to drug delivery in solid tumors. , 1994, Scientific American.
[11] A. Rehemtulla,et al. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. , 1991, The Journal of biological chemistry.
[12] J. Healey,et al. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Zardi,et al. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors , 1989, The Journal of cell biology.
[14] F. Burrows,et al. Vascular targeting--a new approach to the therapy of solid tumors. , 1994, Pharmacology & therapeutics.
[15] K. Jellinger,et al. Increased levels of type VIII collagen in human brain tumours compared to normal brain tissue and non-neoplastic cerebral disorders. , 1991, British Journal of Cancer.
[16] A. Ullrich,et al. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. , 1993, Cancer research.
[17] S. Kumar,et al. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues , 1993, International journal of cancer.
[18] O. Fodstad,et al. Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen. , 1988, Cancer research.
[19] W. Kisiel,et al. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. , 1993, Journal of the National Cancer Institute.